Skip Navigation



Carcinogenesis Advance Access published online on January 30, 2004

Carcinogenesis, doi:10.1093/carcin/bgh067
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
25/5/723    most recent
bgh067v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kumagai, H.
Right arrow Articles by Hattori, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumagai, H.
Right arrow Articles by Hattori, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats

Hitomi Kumagai 1, Ken-ichi Mukaisho 2*, Hiroyuki Sugihara 2, Koichi Miwa 3, Gaku Yamamoto 4, and Takanori Hattori 2

1 Department of Pathology, Shiga University of Medical Science, Seta-tsukinowa-cho, Ohtsu, Shiga, 520-2192, Japan; Department of Dental & Oral surgery, Shiga University of Medical Science, Seta-tsukinowa-cho, Ohtsu, Shiga, 520-2192, Japan
2 Department of Pathology, Shiga University of Medical Science, Seta-tsukinowa-cho, Ohtsu, Shiga, 520-2192, Japan
3 Department of Gastroenterologic Surgery, Kanazawa University, Kanazawa, 920-8641, Japan
4 Department of Dental & Oral surgery, Shiga University of Medical Science, Seta-tsukinowa-cho, Ohtsu, Shiga, 520-2192, Japan

* Corresponding author. E-mail: mukaisho{at}belle.shiga-med.ac.jp.

Received 1 September 2003 ; revised 6 December 2003 ; accepted 16 December 2003

Abstract

Several epidemiological cohort studies have suggested that duodeno-gastroesophageal reflux per se induces Barrett's esophagus leading to increased risk for the development of esophageal adenocarcinoma (EAC). However, the exact causative factors behind EAC remain unclear. Recently, we designed a new duodenal contents reflux model which retained normal stomach function. In this model, duodenal contents flowed back into esophagus to stomach resulting in reentry to esophagus through the site of esophgojejunostomy, repeatedly. To elucidate the factors underlying the development of EAC, thiazolidine-4-carboxylic acid (thioproline; TPRO) was applied to the new reflux models as a nitrite scavenger and as a probe to detect reactive nitrogen species (RNS). Post-operatively, thirty-one animals were divided into two groups according to diet. Animals belonging to the control group were given normal diet (n=18), while the TPRO group was given food containing 0.5% TPRO (n=13). All esophageal sections in both groups were examined using hematoxylin-eosin staining and immunohistochemical analysis of inducible nitric oxide synthase (iNOS). EACs developed in 7 out of 18 rats (38.9%) of the control group, whereas no EACs were detected in the TPRO group (Fisher's exact test, p<0.05). Conversely, esophageal squamous cell carcinoma (ESCC) was detected in 1 out of 18 rats (5.6%) of the control group and in 1 out of 13 rats (7.7%) of the TPRO group. The incidence of ESCC was not significantly different between the two groups (p=0.671). iNOS protein was overexpressed in Barrett's esophagus of both groups. The present results suggest that RNS such as nitric oxide (NO), and peroxynitrite (ONOO-) and nitroso-compounds derived from reflux of duodenal contents play an important role in the development of EAC, and the primary causes 2 of ESCC and EAC may differ.

Barrett's esophagus, gastroduodenal reflux, bile acid, thioproline, iNOS
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Therapeutic Advances in GastroenterologyHome page
J. A. Abrams
Review: Chemoprevention of esophageal adenocarcinoma
Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 7 - 18.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.